These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 30536479

  • 1. Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high-dose cisplatin-based chemoradiotherapy.
    Driessen CML, Leijendeckers J, Snik A, van der Graaf WTA, de Boer JP, Gelderblom H, Kaanders JHAM, Takes R, van Herpen CML.
    Head Neck; 2019 Feb; 41(2):488-494. PubMed ID: 30536479
    [Abstract] [Full Text] [Related]

  • 2. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
    Driessen CM, de Boer JP, Gelderblom H, Rasch CR, de Jong MA, Verbist BM, Melchers WJ, Tesselaar ME, van der Graaf WT, Kaanders JH, van Herpen CM.
    Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
    [Abstract] [Full Text] [Related]

  • 3. Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial.
    Driessen CML, Groenewoud JMM, de Boer JP, Gelderblom H, van der Graaf WTA, Prins JB, Kaanders JHAM, van Herpen CML.
    Support Care Cancer; 2018 Apr; 26(4):1233-1242. PubMed ID: 29230548
    [Abstract] [Full Text] [Related]

  • 4. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ, Öksüz DÇ, Dyker K, Coyle C, Şen M.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e237-43. PubMed ID: 21620580
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant docetaxel, cisplatin, 5-fluorouracil before concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck versus concomitant chemoradiotherapy: a phase II feasibility study.
    Ghi MG, Paccagnella A, D'Amanzo P, Mione CA, Fasan S, Paro S, Mastromauro C, Carnuccio R, Turcato G, Gatti C, Pallini A, Nascimben O, Biason R, Oniga F, Medici M, Rossi F, Fila G.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):481-7. PubMed ID: 15145166
    [Abstract] [Full Text] [Related]

  • 6. [Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
    Chilimoniuk M, Olszewska E, Maksimowicz T.
    Pol Merkur Lekarski; 2010 Dec 01; 29(174):357-60. PubMed ID: 21298984
    [Abstract] [Full Text] [Related]

  • 7. Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study.
    Paccagnella A, Ghi MG, Loreggian L, Buffoli A, Koussis H, Mione CA, Bonetti A, Campostrini F, Gardani G, Ardizzoia A, Dondi D, Guaraldi M, Cavallo R, Tomio L, Gava A, Gruppo di Studio Tumori della Testa e del Collo XRP 6976 F/2501 Study.
    Ann Oncol; 2010 Jul 01; 21(7):1515-1522. PubMed ID: 20032123
    [Abstract] [Full Text] [Related]

  • 8. Comparison of induction chemotherapy with docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by radiation vs concurrent chemoradiotherapy with TPF in patients with locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M.
    Clin Oncol (R Coll Radiol); 2005 May 01; 17(3):148-52. PubMed ID: 15900997
    [Abstract] [Full Text] [Related]

  • 9. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
    Haddad R, O'Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D, Clark J, Sarlis N, Lorch J, Beitler JJ, Limaye S, Riley S, Posner M.
    Lancet Oncol; 2013 Mar 01; 14(3):257-64. PubMed ID: 23414589
    [Abstract] [Full Text] [Related]

  • 10. Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.
    Okano S, Enokida T, Onoe T, Ota Y, Motegi A, Zenda S, Akimoto T, Tahara M.
    Int J Clin Oncol; 2019 Jul 01; 24(7):789-797. PubMed ID: 30796560
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
    Teo M, Karakaya E, Young CA, Dyker KE, Coyle C, Sen M, Prestwich RJ.
    Clin Oncol (R Coll Radiol); 2013 Nov 01; 25(11):647-53. PubMed ID: 23948462
    [Abstract] [Full Text] [Related]

  • 12. TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck.
    Strojan P, Grašič Kuhar C, Žumer B, Kadivec M, Karner K, Fajdiga I, Jančar B, Gale N, Poljak M, Kocjan BJ, Zakotnik B.
    Head Neck; 2014 Nov 01; 36(11):1555-61. PubMed ID: 24123552
    [Abstract] [Full Text] [Related]

  • 13. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W, Bölke E, Kammers K, Gerber PA, Orth K, Gripp S, Matuschek C.
    Radiother Oncol; 2016 Feb 01; 118(2):238-43. PubMed ID: 26589131
    [Abstract] [Full Text] [Related]

  • 14. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
    Lowe NM, Bernstein JM, Mais K, Garcez K, Lee LW, Sykes A, Thomson DJ, Homer JJ, West CM, Slevin NJ.
    J Cancer Res Clin Oncol; 2018 Feb 01; 144(2):389-401. PubMed ID: 29222650
    [Abstract] [Full Text] [Related]

  • 15. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Tsukuda M, Ishitoya J, Matsuda H, Horiuchi C, Taguchi T, Takahashi M, Nishimura G, Kawakami M, Watanabe M, Niho T, Kawano T, Ikeda Y, Sakuma Y, Shiono O, Komatsu M.
    Cancer Chemother Pharmacol; 2010 Sep 01; 66(4):729-36. PubMed ID: 20033810
    [Abstract] [Full Text] [Related]

  • 16. Induction chemotherapy before chemoradiotherapy in locally advanced head and neck cancer: the future?
    Paccagnella A, Mastromauro C, D'Amanzo P, Ghi MG.
    Oncologist; 2010 Sep 01; 15 Suppl 3():8-12. PubMed ID: 21036883
    [Abstract] [Full Text] [Related]

  • 17. Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer.
    Janinis J, Papadakou M, Panagos G, Panousaki A, Georgoulias V, Hatzidaki D, Lefantzis D, Dokianakis G.
    Am J Clin Oncol; 2001 Jun 01; 24(3):227-31. PubMed ID: 11404490
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of dose-modified docetaxel plus cisplatin-based induction chemotherapy in Asian patients with locally advanced head and neck cancer.
    Huang CE, Lu CH, Chen PT, Chan CH, Chen WC, Wang WH, Wu JY, Kuan FC, Lee KD, Chen CC.
    J Clin Pharm Ther; 2012 Jun 01; 37(3):342-7. PubMed ID: 21950487
    [Abstract] [Full Text] [Related]

  • 19. Induction docetaxel and S-1 followed by concomitant radiotherapy with low-dose daily cisplatin in locally advanced head and neck carcinoma.
    Kim HR, Lee CG, Choi EC, Kim JH, Koh YW, Cho BC.
    Head Neck; 2016 Apr 01; 38 Suppl 1():E1653-9. PubMed ID: 26890965
    [Abstract] [Full Text] [Related]

  • 20. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma.
    Yang WC, Chen CH, Tang JY, Wu CF, Liu YC, Sun Y, Lin SF.
    Anticancer Res; 2014 Jul 01; 34(7):3765-73. PubMed ID: 24982400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.